Related Experiment Video
Updated: May 6, 2026

CD4+ T-Lymphocyte Capture Using a Disposable Microfluidic Chip for HIV
Published on: October 1, 2007
Exclusion-Based Capture and Enumeration of CD4+ T Cells from Whole Blood for Low-Resource Settings
Alexander L Howard1, Hannah M Pezzi2, David J Beebe2
1University of Wisconsin-Madison, WI, USA ahoward3@wisc.edu.
Insights
A new, low-cost method accurately counts CD4(+) T-helper cells in HIV patients using immiscible filtration. This technique enables better disease monitoring in resource-limited settings without expensive equipment.
Area of Science:
- Biomedical Engineering
- Immunology
- Medical Diagnostics
Background:
- CD4(+) T-helper cell count is crucial for monitoring HIV/AIDS progression and guiding treatment.
- Current methods like flow cytometry are expensive and inaccessible in many developing countries.
- There is a need for cost-effective, low-volume blood sample methods for CD4(+) T-cell enumeration.
Purpose of the Study:
- To develop and validate a cost-effective system for accurate CD4(+) T-helper cell counting.
- To provide a viable alternative to flow cytometry for HIV patient monitoring in resource-limited settings.
- To enable improved disease progression and therapy response tracking for HIV patients.
Main Methods:
- Utilized two serially-operated immiscible phase exclusion-based cell isolations.
- Employed Immiscible Filtration Assisted by Surface Tension (IFAST) for T-helper cell isolation.
- Integrated a rapid fluorescent readout for accurate cell counting.
Main Results:
- The IFAST method demonstrated comparable performance to the established Dynal T4 Quant Kit.
- The system is sensitive for CD4 counts indicative of immunocompromised patients (below 200 cells/µL).
- Achieved accurate T-helper cell isolation and counting from smaller blood volumes at lower cost.
Conclusions:
- The developed IFAST system offers a cost-effective and accurate solution for CD4(+) T-cell counting.
- This high-throughput, automatable method can significantly improve HIV patient care in resource-limited areas.
- The open, simple-to-operate devices make the technique suitable for widespread adoption.
Abstract:
In developing countries, demand exists for a cost-effective method to evaluate human immunodeficiency virus patients' CD4(+) T-helper cell count. The TH (CD4) cell count is the current marker used to identify when an HIV patient has progressed to acquired immunodeficiency syndrome, which results when the immune system can no longer prevent certain opportunistic infections. A system to perform TH count that obviates the use of costly flow cytometry will enable physicians to more closely follow patients' disease progression and response to therapy in areas where such advanced equipment is unavailable. Our system of two serially-operated immiscible phase exclusion-based cell isolations coupled with a rapid fluorescent readout enables exclusion-based isolation and accurate counting of T-helper cells at lower cost and from a smaller volume of blood than previous methods. TH cell isolation via immiscible filtration assisted by surface tension (IFAST) compares well against the established Dynal T4 Quant Kit and is sensitive at CD4 counts representative of immunocompromised patients (less than 200 TH cells per microliter of blood). Our technique retains use of open, simple-to-operate devices that enable IFAST as a high-throughput, automatable sample preparation method, improving throughput over previous low-resource methods.
More Related Videos
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021